Adage Capital Partners Gp, L.L.C. Adicet Bio, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.9 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding ACET
# of Institutions
71Shares Held
59MCall Options Held
7.3KPut Options Held
39.3K-
Orbimed Advisors LLC San Diego, CA11.4MShares$11.4 Million0.3% of portfolio
-
Tang Capital Management LLC San Diego, CA8.15MShares$8.15 Million0.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.54MShares$7.54 Million0.12% of portfolio
-
Goldman Sachs Group Inc New York, NY3.75MShares$3.75 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$3.21 Million0.0% of portfolio
About Adicet Bio, Inc.
- Ticker ACET
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,030,800
- Market Cap $40M
- Description
- Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...